UY39705A - Novedosos compuestos útiles como agonistas de sting y sus usos - Google Patents

Novedosos compuestos útiles como agonistas de sting y sus usos

Info

Publication number
UY39705A
UY39705A UY0001039705A UY39705A UY39705A UY 39705 A UY39705 A UY 39705A UY 0001039705 A UY0001039705 A UY 0001039705A UY 39705 A UY39705 A UY 39705A UY 39705 A UY39705 A UY 39705A
Authority
UY
Uruguay
Prior art keywords
novel compounds
compounds useful
sting agonists
compounds
sting
Prior art date
Application number
UY0001039705A
Other languages
English (en)
Spanish (es)
Inventor
Wei Long
Yanping Wang
Yang Ye
Xiuwei Li
Guiqun Yang
Fashun Yan
Original Assignee
Jacobio Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jacobio Pharmaceuticals Co Ltd filed Critical Jacobio Pharmaceuticals Co Ltd
Publication of UY39705A publication Critical patent/UY39705A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
UY0001039705A 2021-03-30 2022-03-29 Novedosos compuestos útiles como agonistas de sting y sus usos UY39705A (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
CN2021083783 2021-03-30
CN2021090945 2021-04-29
CN2021111479 2021-08-09
CN2021128942 2021-11-05
CN2021130097 2021-11-11
CN2021138806 2021-12-16
CN2021143043 2021-12-30
CN2022071548 2022-01-12

Publications (1)

Publication Number Publication Date
UY39705A true UY39705A (es) 2022-10-31

Family

ID=83457956

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001039705A UY39705A (es) 2021-03-30 2022-03-29 Novedosos compuestos útiles como agonistas de sting y sus usos

Country Status (8)

Country Link
US (1) US20240116909A1 (cg-RX-API-DMAC10.html)
EP (1) EP4313962B1 (cg-RX-API-DMAC10.html)
JP (1) JP2024511832A (cg-RX-API-DMAC10.html)
CN (1) CN117203194A (cg-RX-API-DMAC10.html)
AR (1) AR125608A1 (cg-RX-API-DMAC10.html)
TW (1) TW202302579A (cg-RX-API-DMAC10.html)
UY (1) UY39705A (cg-RX-API-DMAC10.html)
WO (1) WO2022206725A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250108123A1 (en) * 2021-12-17 2025-04-03 Jacobio Pharmaceuticals Co., Ltd. Compound-linker constructs comprising novel compounds useful as sting agonists and uses thereof
WO2024032782A1 (en) * 2022-08-12 2024-02-15 Jacobio Pharmaceuticals Co.Ltd. Vaccine adjuvants and uses thereof
TW202615010A (zh) * 2024-06-24 2026-04-16 大陸商北京加科思新藥研發有限公司 藥物連接子、其偶聯物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10793557B2 (en) 2018-04-03 2020-10-06 Merck Sharp & Dohme Corp. Sting agonist compounds
US11702430B2 (en) * 2018-04-03 2023-07-18 Merck Sharp & Dohme Llc Aza-benzothiophene compounds as STING agonists
DK4004002T3 (da) * 2019-07-22 2024-09-30 Lupin Ltd Makrocykliske forbindelser som sting-agonister samt fremgangsmåder og anvendelser dermed

Also Published As

Publication number Publication date
AR125608A1 (es) 2023-08-02
EP4313962B1 (en) 2026-07-22
TW202302579A (zh) 2023-01-16
CN117203194A (zh) 2023-12-08
EP4313962A4 (en) 2025-02-26
JP2024511832A (ja) 2024-03-15
WO2022206725A1 (en) 2022-10-06
EP4313962A1 (en) 2024-02-07
US20240116909A1 (en) 2024-04-11

Similar Documents

Publication Publication Date Title
NI201900029A (es) COMPUESTOS DE BENZO[b]TIOFENO COMO AGONISTAS DE STING
UY38448A (es) Compuestos de azol-amida pesticidamente activos
EA201890450A1 (ru) Циклические динуклеотидные соединения в качестве агонистов sting
CL2021002519A1 (es) Compuestos de diazina-amida activos como pesticidas.
MX2021012162A (es) Compuestos de diazina-amida activos como pesticidas.
CY1125004T1 (el) Ετεροαρυλο υποκατεστημενες βητα-υδροξυαιθυλαμινες για χρηση στη θεραπεια της υπεργλυκαιμιας
MX2019001096A (es) Antagonistas del receptor 7/8 tipo toll (tlr7/8) y uso de los mismos.
PY1923494A (es) Derivados de n-(3-(7h-pirrolo[2,3-d]pirimidin-4-il)fenil)benzamida
ECSP18024565A (es) Benzamidas sustituidas con isoxazolinas y análalogos como insecticidas
UY39676A (es) Moduladores de sting (estimulador de genes de interferón)
MX2021015188A (es) Moduladores de nueva generacion del estimulador de genes de interferon (sting).
UY39517A (es) Inhibidores de la btk
AR072510A1 (es) Derivados de triazinas y de uracilos, su preparacion y su aplicacion en terapeutica humana
ECSP22030481A (es) Compuestos de amina cíclica activos como plaguicidas
CO6670585A2 (es) Promotores de apotosis n-acilsufonamidas
CR20150419A (es) Derivados sustituidos del ácido bisfenil butanóico fosfónico como inhibidores de la nep
UY39694A (es) Novedosos compuestos útiles como agonistas de sting y sus usos
UY36416A (es) 1-[2-(aminometil)bencil]-2-tioxo-1,2,3,5-tetrahidro-4h-pirrolo[3,2-d]pirimidin-4-onas como inhibidores de la mieloperoxidasa
CR20220014A (es) Derivados de 3,6-diamino-piridazin-3-ilo, composiciones farmacéuticas que los contienen y sus usos como agentes proapoptóticos
AR113958A1 (es) Macrociclos a como inhibidores de pde1
PY2201650A (es) Nuevos derivados de espirociclohexano, composiciones farmacéuticas que los contienen y sus usos como inhibidores antiapoptóticos
UY39865A (es) Pirazin-2-carboxamidas sustituidas como inhibidores de hpk1 para el tratamiento del cáncer
CO2024000832A2 (es) Inhibidores de transglutaminasas
AR133276A1 (es) Nuevos derivados de pirazolopiridina
CO2023017151A2 (es) Inhibidores de ripk1 de nicotinamida